MEZZATESTA, Maria Lina
 Distribuzione geografica
Continente #
NA - Nord America 3.960
EU - Europa 1.853
AS - Asia 1.442
SA - Sud America 355
AF - Africa 220
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
AN - Antartide 1
Totale 7.841
Nazione #
US - Stati Uniti d'America 3.791
SG - Singapore 665
IT - Italia 577
CN - Cina 550
IE - Irlanda 396
UA - Ucraina 374
BR - Brasile 316
CI - Costa d'Avorio 182
DE - Germania 161
CA - Canada 145
RU - Federazione Russa 105
SE - Svezia 66
GB - Regno Unito 45
VN - Vietnam 41
KR - Corea 26
TR - Turchia 23
FR - Francia 21
AR - Argentina 18
IN - India 17
JP - Giappone 17
PL - Polonia 16
IQ - Iraq 14
MX - Messico 14
AT - Austria 13
SN - Senegal 13
AE - Emirati Arabi Uniti 12
BE - Belgio 12
CH - Svizzera 12
UZ - Uzbekistan 12
HK - Hong Kong 11
BD - Bangladesh 10
ZA - Sudafrica 10
EC - Ecuador 9
NO - Norvegia 9
ES - Italia 8
JO - Giordania 8
NL - Olanda 8
FI - Finlandia 7
LB - Libano 7
PK - Pakistan 7
IR - Iran 5
RO - Romania 5
AU - Australia 4
HN - Honduras 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EU - Europa 3
LT - Lituania 3
PE - Perù 3
SA - Arabia Saudita 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
CO - Colombia 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
ID - Indonesia 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
NG - Nigeria 2
NP - Nepal 2
QA - Qatar 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
ET - Etiopia 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SD - Sudan 1
TN - Tunisia 1
Totale 7.841
Città #
Dallas 684
Santa Clara 682
Singapore 414
Jacksonville 412
Dublin 396
Chandler 357
Abidjan 182
Boardman 181
Catania 158
Los Angeles 137
Chicago 119
Nanjing 112
Andover 108
Lawrence 108
Cambridge 106
Toronto 105
Ashburn 101
Bremen 101
Beijing 92
Hefei 65
Des Moines 64
San Mateo 55
Civitanova Marche 47
Belpasso 43
Wilmington 43
Hebei 34
Shenyang 33
São Paulo 33
Nanchang 31
Palermo 31
Jiaxing 29
Ottawa 29
Grafing 28
Council Bluffs 26
Seoul 26
Tianjin 20
Changsha 19
Mendicino 18
Tokyo 17
Ho Chi Minh City 16
Saint Petersburg 16
Messina 15
Bologna 14
Milan 14
Columbus 13
Dakar 13
Munich 13
Brolo 12
Brussels 12
Syracuse 12
The Dalles 12
Falls Church 11
Mascalucia 11
Hong Kong 10
London 10
San Francisco 10
Boston 9
Brooklyn 9
Frankfurt am Main 9
Moscow 9
Tromsø 9
Warsaw 9
Brasília 8
Kunming 8
New York 8
Rio de Janeiro 8
Amman 7
Ankara 7
Belo Horizonte 7
Dong Ket 7
Hangzhou 7
Jinan 7
Rome 7
Agrigento 6
Augusta 6
Bronte 6
Rometta 6
Sorocaba 6
Washington 6
Baghdad 5
Den Haag 5
Johannesburg 5
Mexico City 5
Montreal 5
Ningbo 5
Porto Alegre 5
Seattle 5
Stefania 5
Tashkent 5
Campinas 4
Charlotte 4
Constanța 4
Curitiba 4
Dubai 4
Fiumefreddo di Sicilia 4
Frankfurt Am Main 4
Guangzhou 4
Guarulhos 4
Hanoi 4
Helsinki 4
Totale 5.725
Nome #
Attività antibatterica di netilmicina e netilmicina/desametasone, in paragone con altri antibiotici, verso Gram-positivi e Gram-negativi isolati da infezioni oculari. 150
A multicenter study on central venous catheter-associated infections in Italy 129
Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy 114
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions 106
Infections with VIM-1 metallo beta-lactamase producing Enterobacter cloacae and their correlation with clinical outcome 104
Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy 101
Attività antibatterica in vitro dell’associazione thrimethoprim/sulfadiazina 98
Activity of Tigecycline against well characterized multi-resistant Gram-positive strains 98
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method. 97
Cefditoren versus community acquired respiratory pathogens: time kill studies 96
Aspetti Microbiologici e legislativi delle piscine:valutazione dell’azione batterica di due disinfettanti a base di cloro, comunemente utilizzati in piscina 96
Infections of cardiovascular implantable electronic devices: 14 years of experience in an Italian hospital 94
Bactericidal activity of ertapenem against major intra-abdominal pathogens 92
Extended-spectrum beta-lactamase-producing and carbapenemase- producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin 92
Overview of the Clinical and Molecular Features of Legionella Pneumophila: Focus on Novel Surveillance and Diagnostic Strategies 92
Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury: A case report. 90
In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci. 89
Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence 89
Attività in vitro di tigeciclina e altri antibiotici verso Acinetobacter baumannii isolati da infezioni gravi in Italia 88
Detection of the IncX3 plasmid carrying blaKPC-3in a Serratia marcescens strain isolated from a kidney-liver transplanted patient 88
Study on the in-vitro activity of LY333328 against Gram-positive cocci 87
Antibacterial activity of PZ-601 against well-characterized and recent clinical isolates of methicillin-resistant Staphylococcus aureus 87
Antipneumococcal activity of telithromycin in comparison with other drugs in relation to the presence of different resistance genes 86
Attività Battericida di Cefditoren nei Confronti di Patogeni Respiratori Acquisiti in Comunità 86
Extensively drug-resistant ArmA-producing Acinetobacter baumannii in an Italian intensive care unit 85
Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy 85
Biofilm production and correlation with agr-allele distribution in medical-devices associated with Staphylococcus aureus 84
Flora batterica e micotica nel condotto uditivo esterno 83
Gain-in omic signatures of colistin-resistant Acinetobacter baumannii undergoing colistin therapy. 82
Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis 82
In vitro activity of Sulbactam/ampicillin and other antibiotics against clinical isolates of Haemophilus species and Branhamella catarrhalis 81
Gold standard susceptibility testing of fosfomycin in Staphylococcus aureus and Enterobacterales using a new agar dilution panel® 81
Antibacterial activity of netilmicin and netilmicin/desametasone fixed combination against the most common ocular isolates 80
Attività antibatterica in vitro di dactimicina (ST 900), nuovo antibiotico aminoglucosidico nei confronti di bacilli Gram negativi 80
Activity of telithromycin against multi-drug resistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance determinants 80
In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae 80
In vitro Activity of Tigecycline and Comparators against Carbapenem-Susceptible and Resistant Acinetobacter baumannii Isolated from Severe Infections in Italy 79
Antibacterial activity of Netilmicin and Netilmicin/Dexamethasone fixed combination against the most common ocular isolates 79
Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. 78
Attività in vitro di piperacillina/tazobactam in paragone ad altri antibiotici nei confronti di germi multiresistenti 78
Comparative In-Vitro Activity of Piperacillin and Piperacillin Plus Tazobactam Towards Beta-Lactamase Producing Clinical Isolates 77
Spread of Enterobacteriaceae carrying the PER-1 extended-spectrum β-lactamase gene as a chromosomal insert: a report from Italy 76
Preliminary results on the antibacterial activity of sagamicin towards microrganisms responsible for ocular pathology 76
Emergence of an extensively drug-resistant ArmA- and KPC-2-producing ST101 Klebsiella pneumoniae clone in Italy. 75
Bactericidal activity of doripenem against carbapenem-resistant Acinetobacter baumanni 74
In vitro evidence of the synergistic interaction of ceftopibrole and other antibiotics against multidrug-resistant Gram-negative isolates 74
Attività antibatterica di cefditoren e altri antibiotici verso S.pneumoniae ed H.influenzae isolati da infezioni respiratorie comunitarie in Italia 73
Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants 73
Spettro di resistenza agli antibiotici in patogeni isolati da reparti di terapia intensiva: Studio Policentrico Retrospettivo Italiano 72
SNPs in genes involved in lipid a phosphoethanolamine transferase over-expression and proline biosynthesis are associated with colistin resistance in Acinetobacter baumannii 71
Attività di Ofloxacin nei confronti di batteri responsabili di infezioni oculari esterne 71
Identification and Characterization of a New Metallo-_-Lactamase, IND-5, from a Clinical Isolate of Chryseobacterium indologenes 70
Correlazione tra il background genetico e le varianti di SCCmec dei maggiori cloni di Staphylococcus aureus meticillino-resistenti (MRSA), circolanti in Italia 69
Attività antibatterica in vitro di Linezolid nei confronti di Stafilococchi ed Enterococchi isolati in Italia 69
Incidenza ed antibiotico resistenza delle diverse specie di stafilococco in ambienti nosocomiali della Sicilia Orientale 69
Mutation- and Transcription-Driven Omic Burden of Daptomycin/Dalbavancin-R and Glycopeptide-RS Fitness Costs in High-Risk MRSA: A Nexus in Antimicrobial Resistance Mechanisms—Genome Proneness—Compensatory Adaptations 68
Molecular Epidemiology of Enterococci with High-Level Resistance to Aminoglycosides 68
In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy 68
Fitness Burden for the Stepwise Acquisition of First- and Second-Line Antimicrobial Reduced-Susceptibility in High-Risk ESKAPE MRSA Superbugs 67
In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates 67
Circolazione epidemiologica di beta-lattamasi: superamento delle resistenze da parte della associazione amoxicillina/acido clavulanico 65
High-level resistance to aminoglycosides in enterococci: incidence and alternative active antibiotic combinations in vitro 65
Observations on the tollerance and the paradoxical effect in Enterococci 64
In vitro activity of tigecycline and comparators against Acinetobacter baumannii isolated from severe infections in Italy 64
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy 63
Role of empirical and definitive therapy in hospitalised patients with bloodstream infections caused by extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae: a prospective cohort observational study. 63
Comparative activity of linezolid against Staphylococci and Enterococci isolated in Italy 63
Clonal diffusion of colistin resistant OXA-23 Acinetobacter baumannii from 4 different hospitals: is really one clone only? 62
Three major A.baumannii clones account for all carbapenem-resistant strains in Italy 62
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae. 62
In vivo multiclonal transfer of blaKPC-3 from Klebsiella pneumoniae to Escherichia coli in surgery patients 62
Principali cloni di A.baumannii carbapenemi-resistenti circolanti in Italia 61
Tigecycline in vitro activity against clinically-relevant multi-resistant Gram-positive and Gram-negative pathogens 61
Cell-free supernatant of Lactobacillus gasseri 1A-TV shows a promising activity to eradicate carbapenem-resistant Klebsiella pneumoniae colonization 61
Bactericidal activity of doripenem against carbapenem-resistant acinetobacter baumannii 60
Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs 59
Dall’emergenza alla diagnosi 59
In vitro activity of fosfomycin trometamol and other oral antibiotics against multi-drug-resistant uropathogens 59
In vitro evaluation of daptomycin in combination with other drugs against difficult to treat staphylococci and enterococci 58
PZ-601 antibacterial activity against well-characterised and fresh Enterobacteriaceae isolates 57
Risk of treatment failure of A.baumanni infections in solid organ transplantion: discrepancy in interpretation of sensitivity values of colistin in routine microbiological diagnostics. 57
Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate. 57
Italian Nationwide Survey: Extended-spectrum beta-lactamases in isolates of Enterobacteriaceae from patients and outpatients 56
Studio della Eventuale Interferenza di Cefatrizina sulla Flora Batterica Intestinale e del Cavo Orale: Breve Nota 56
Colistin-resistant Acinetobacter baumannii: in vitro synergistic activity of antibiotic combinations by time-kill curves 56
Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit 56
Outbreak of KPC-3-producing, and colistin resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. 55
Correlation between icaAD expression and biofilm production in S.epidermidis 55
ica A and ica D co-expression determines biofilm production in Staphylococcus epidermidis and ica-operon distribution is independent of the source of isolation 55
Class I integron-borne blaVIM-1 carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia 55
Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae. 55
Preliminary results on the antbacterial activity of sagamicin towards pathology 54
Preliminary results on the antibacterial and killing activity of lomefloxacin 54
Prolonged bacteraemia caused by VIM-1 metallo-b-lactamase-producing Proteus mirabilis: first report from Italy 54
Comparative activity of linezolid against Staphylococci and Enterococci isolated in Italy 53
Valutazione dell’azione battericida di due disinfettanti a base di cloro, comunemente usati in piscina 53
Polimorfismi genomici di Stafilococchi coagulasi-negativi isolati da catetere 52
Italian nationwide survey: extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae from inpatients and outpatients 51
Diffusione di erm(B), mef(A) e tet(M) mediata da elementi mobili: localizzazione e variabilità genomica in Streptococchi orali 51
Gentamicin-resistant KPC-producing Klebsiella pneumoniae: a new Italian multidrug-resistant (MDR) clone 50
Totale 7.388
Categoria #
all - tutte 27.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021509 0 0 0 8 166 25 90 4 83 11 92 30
2021/2022819 105 107 9 17 125 16 113 20 92 3 11 201
2022/20231.257 116 53 16 178 109 221 6 175 307 11 39 26
2023/2024638 35 102 18 51 19 159 9 15 1 11 96 122
2024/20252.204 14 290 112 106 534 235 87 77 165 208 171 205
2025/20261.528 320 362 761 85 0 0 0 0 0 0 0 0
Totale 8.000